HPV vaccine schedule

To help protect your child against certain HPV-related cancers and diseases, complete the GARDASIL 9 vaccine series

HPV, human papillomavirus.

The CDC notes that HPV vaccination may begin at age 9, and recommends it routinely for the 11- to 12-year-old age group.

See the dosing schedule below and talk to your child’s doctor about when your child should start.

Make sure your child completes their recommended vaccine schedule.

The number of recommended doses is based on age when the first dose is given.

If your child is 9- to 14-years-old, your child’s doctor will determine whether your child needs a 2-dose or 3-dose schedule of GARDASIL 9.

HPV Vaccine Dosing Schedule for Children 9 to 14 Years Old

aIf the second shot is given earlier than 5 months after the first shot, your child will need to get a third shot at least 4 months after the second shot was given.

For individuals 15- to 45-years-old

HPV Vaccine Dosing Schedule for Individuals 15 to 45 Years Old

Fainting can happen after getting an HPV vaccine. Sometimes people who faint can fall and hurt themselves. For this reason, your child’s doctor may ask your child to sit or lie down for 15 minutes after he or she gets GARDASIL 9. Some people who faint might shake or become stiff, which may need treatment.

If your child misses a dose of GARDASIL 9

Make sure that your child gets all doses recommended by your health care professional so that your child gets the best protection.

If your child misses a dose, tell their health care professional and they will decide when to give the missed dose.

To help avoid a missed dose of GARDASIL 9, make an appointment for your child’s next dose before leaving the doctor’s office.

Some questions parents may have about GARDASIL 9

What are the ingredients of GARDASIL 9?

The ingredients are proteins of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58, amorphous aluminum hydroxyphosphate sulfate, yeast protein, sodium chloride, L-histidine, polysorbate 80, sodium borate, and water.

For more information on GARDASIL 9, talk to your child’s doctor.

Explore FAQs

Can my child get GARDASIL 9 with other vaccines?

Yes. Your child may get GARDASIL 9 at the same time as:

  • Menactra [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine]a
  • Adacel [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap)]a

Studies show that when GARDASIL 9 was given at the same time as Menactra and Adacel, there was more swelling in the location of the shot.

aMenactra [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] and Adacel [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap)] are the trademarks of their respective owners and are not trademarks of Merck Sharp & Dohme LLC.

Explore FAQs

See more FAQs

Explore related topics

About GARDASIL 9

About GARDASIL 9

About HPV-related cancers

About HPV-related cancers

Safety and side effects

Safety and side effects

What is GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)?

GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.

 

GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL 9 does not prevent all types of cervical, vulvar, vaginal, anal, or head and neck cancers.

 

Vaccination does not remove the need for recommended cancer screenings, and it’s important to get routine cervical cancer screenings. GARDASIL 9 does not
treat HPV infection, cancer, or genital warts.

 

GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.

  • For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6-12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
  • For persons 15 through 45 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.

The appropriate dosing schedule will be determined by a health care professional.

Important Safety Information

Anyone with an allergic reaction to the ingredients of GARDASIL 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

 

Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, the health care professional may ask the person getting GARDASIL 9 to sit or lie down for 15 minutes after getting the vaccine. Some people who faint might shake or become stiff.

 

The side effects include pain, swelling, redness, itching, bruising, bleeding, and a lump where you got the shot; headache; fever; nausea; and dizziness.

 

Only a doctor or health care professional can decide if GARDASIL 9 is right for your child.

 

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please read the Patient Information for GARDASIL 9, and discuss it with your or your child’s doctor. The physician Prescribing Information also is available.

What is GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)?

GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.

 

GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL 9 does not prevent all types of cervical, vulvar, vaginal, anal, or head and neck cancers.

 

Vaccination does not remove the need for recommended cancer screenings, and it’s important to get routine cervical cancer screenings. GARDASIL 9 does not
treat HPV infection, cancer, or genital warts.

 

GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.

  • For persons 9 through 14 years of age, GARDASIL 9 can be given using a 2-dose or 3-dose schedule. For the 2-dose schedule, the second shot should be given 6-12 months after the first shot. If the second shot is given less than 5 months after the first shot, a third shot should be given at least 4 months after the second shot. For the 3-dose schedule, the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.
  • For persons 15 through 45 years of age, GARDASIL 9 is given using a 3-dose schedule; the second shot should be given 2 months after the first shot and the third shot should be given 6 months after the first shot.

The appropriate dosing schedule will be determined by a health care professional.

GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer,

GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.

Important Safety Information for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant)

Anyone with an allergic reaction to the ingredients of GARDASIL 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

 

Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, the health care professional may ask the person getting GARDASIL 9 to sit or lie down for 15 minutes after getting the vaccine. Some people who faint might shake or become stiff.

 

The side effects include pain, swelling, redness, itching, bruising, bleeding, and a lump where you got the shot; headache; fever; nausea; and dizziness.

 

Only a doctor or health care professional can decide if GARDASIL 9 is right for your child.

 

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

 

Please read the Patient Information for GARDASIL 9, and discuss it with your or your child’s doctor. The physician Prescribing Information also is available.

Anyone with an allergic reaction to the ingredients of GARDASIL 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine,

Anyone with an allergic reaction to the ingredients of GARDASIL 9 or GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.

 

Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, the health care professional may ask the person getting GARDASIL 9